Turnstone Biologics GAAP EPS of -$0.56 misses by $0.36
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2025
0mins
Source: SeekingAlpha
Financial Performance: Turnstone Biologics reported a Q4 GAAP EPS of -$0.56, which missed expectations by $0.36.
Cash Position: As of December 31, 2024, the company had $28.9 million in cash, cash equivalents, and short-term investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
